Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-025812
Filing Date
2012-05-03
Accepted
2012-05-03 14:50:06
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v310004_10q.htm 10-Q 317014
2 EXHIBIT 31.1 v310004_ex31-1.htm EX-31.1 6553
3 EXHIBIT 31.2 v310004_ex31-2.htm EX-31.2 6699
4 EXHIBIT 32 v310004_ex32.htm EX-32 5091
  Complete submission text file 0001144204-12-025812.txt   1574255

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT phli-20120331.xml EX-101.INS 164105
6 XBRL TAXONOMY EXTENSION SCHEMA phli-20120331.xsd EX-101.SCH 16811
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phli-20120331_cal.xml EX-101.CAL 19423
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phli-20120331_def.xml EX-101.DEF 49591
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE phli-20120331_lab.xml EX-101.LAB 119516
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phli-20120331_pre.xml EX-101.PRE 71050
Mailing Address 100 MATAWAN ROAD SUITE 150 MATAWAN NJ 07747
Business Address 100 MATAWAN ROAD SUITE 150 MATAWAN NJ 07747 732-739-2900
PACIFICHEALTH LABORATORIES INC (Filer) CIK: 0001000278 (see all company filings)

EIN.: 223367588 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 10-Q | Act: 34 | File No.: 000-23495 | Film No.: 12809141
SIC: 2833 Medicinal Chemicals & Botanical Products